---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-099516"
form_type: "8-K"
ticker: "SRTS"
cik: "0001494891"
company_name: "Sensus Healthcare, Inc."
filed_at: "2024-11-18T23:59:59+00:00"
generated_at: "2026-05-29T22:58:44.214063+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Sensus Q3 revenues double to $8.8M; net income $1.2M vs loss; targets >50 IG-SRT deals by year-end

## Summary
- Revenue $8.8M (+127% YoY); net income $1.2M ($0.07 diluted EPS) vs net loss $1.5M ($0.09 loss) in Q3 2023.
- Adjusted EBITDA $1.6M vs negative $1.7M; shipped 27 systems (11 in Q3 2023).
- Signed 22 IG-SRT units under Fair Deal as of Sep 30; expects >50 by year-end, generating recurring revenue in 2025.
- Cash $22.6M, no debt; gross margin improved to 59.3% from 51.0%.
- Sold SRT system to Providence Swedish Hospital; strong interest at ASTRO conference.

## SEC filing metadata
- accession: 0001213900-24-099516
- form_type: 8-K
- ticker: SRTS
- cik: 0001494891
- company_name: Sensus Healthcare, Inc.
- filed_at: 2024-11-18T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1494891/000121390024099516/0001213900-24-099516-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1494891/000121390024099516/ea0221591-8k_sensus.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-099516
- JSON: https://secwatch.observer/filing/0001213900-24-099516.json
- Plain text: https://secwatch.observer/filing/0001213900-24-099516.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.